VANCOUVER, British Columbia, Dec. 3, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) announced today that a major step in the application of its proprietary technology for diagnosis of Alzheimer's disease was achieved by the signing of an Agreement with UK-based Fleet Bioprocessing Ltd. (Fleet).
